- Wall Street records moderate gains
- The dollar continues to decline
- Yields on US bonds continue to decline
US leading benchmarks opened cautiously optimistic on Wednesday, with a slight increase across the US500, US30, and US100. During the last trading days of this year, we might see choppy trading due to low year-end volume. The US500 index is posting moderate gains today, supported by a weakening dollar and falling bond yields. The 10-year Treasury yield has slightly decreased, and the 2-year yield has seen a more significant drop. The day's economic agenda is light.
US500
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appOn the main Wall Street index, we are witnessing a continuation of almost euphoric increases. The US500 has gained nearly 17% over the last two months, which is one of the most aggressive increases historically. After breaking through the 4800-4820 point level, around the historical all-time high (ATH), the US500 index is consolidating. In the event of a market correction, the levels to watch are 4800 and 4700-4750 points, where the nearest significant support levels are located.
Source: xStation 5
USDIDX
The dynamic increases in the indices in recent weeks have been supported by a weakening dollar. On the USDIDX chart, we see that the current downward movement is at a crucial support area around 100 points. These levels have already twice this year marked a local bottom. The 99-100.8 point range is key to determining the future direction of the dollar.
Source: xStation 5
Company News
Iovance Biotherapeutics (IOVA.US) shares fall about 22% in pre market trading after the company says the US Food and Drug Administration placed a clinical hold on the IOV-LUN-202 trial on December 22, 2023. This is due to the response to a recently reported Grade 5 (fatal) serious adverse event potentially related to the non-myeloablative lymphodepletion pre-conditioning regimen.
The New York Times has filed a lawsuit against Microsoft (MSFT.US) and OpenAI, accusing them of using its content without permission to train AI models, seeking compensation for the alleged infringement. The lawsuit, highlighting the substantial investment in journalism by The Times, comes amidst stalled negotiations over the use of The Times' intellectual property in generative AI technology. This legal action follows similar claims by authors against OpenAI for copyright infringement.
Cryptocurrency-exposed stocks are surging, outpacing bitcoin itself, amid investor optimism for a potential SEC approval of a spot bitcoin ETF and expectations of lower US interest rates in 2024. Bitcoin mining stocks like Bit Digital (BTBT.US), Marathon Digital (MARA.US), or Coinbase (Coin.US). The rise comes as the market reacts to Barry Silbert stepping down as chairman of Grayscale Investments, fueling hopes for the approval of Grayscale's Bitcoin Trust conversion into an ETF and other products.
NetEase (NTES.US) dropped almost 5.00% in pre-market trading, continuing a downward trend after a brief recovery. This follows China's commitment to refine draft regulations intended to curb excessive online gaming spending. NetEase's stock had previously plummeted by approximately 15% when these proposed rules, which aim to restrict inductive rewards in online games, were initially announced.
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
